Ovarian cancer drug trial halted early: what happened?
Disease control
Terminated
This study aimed to see if the drug niraparib works better than standard chemotherapy before surgery for people with a specific type of advanced ovarian cancer (stage III or IV with HRd). The trial was planned for 36 participants but was stopped early. Researchers wanted to measu…
Phase: PHASE2 • Sponsor: Tesaro, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC